Wellington Shields Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Sell |
4,721
-3,600
| -43% | -$775K | 0.15% | 110 |
|
|
2026
Q1 | $1.81M | Sell |
8,321
-7,047
| -46% | -$1.56M | 0.27% | 78 |
|
|
2025
Q4 | $3.51M | Hold |
15,368
| – | – | 0.51% | 43 |
|
|
2025
Q3 | $3.56M | Sell |
15,368
-20
| -0.1% | -$4.07K | 0.54% | 43 |
|
|
2025
Q2 | $2.86M | Sell |
15,388
-100
| -0.6% | -$18.6K | 0.48% | 47 |
|
|
2025
Q1 | $3.25M | Sell |
15,488
-5,520
| -26% | -$1.07M | 0.59% | 44 |
|
|
2024
Q4 | $3.73M | Sell |
21,008
-24
| -0.1% | -$4.41K | 0.66% | 34 |
|
|
2024
Q3 | $4.15M | Hold |
21,032
| – | – | 0.72% | 27 |
|
|
2024
Q2 | $3.61M | Buy |
21,032
+680
| +3% | +$113K | 0.66% | 33 |
|
|
2024
Q1 | $3.71M | Sell |
20,352
-700
| -3% | -$121K | 0.7% | 31 |
|
|
2023
Q4 | $3.26M | Buy |
21,052
+383
| +2% | +$55.8K | 0.41% | 31 |
|
|
2023
Q3 | $3.08M | Sell |
20,669
-86
| -0.4% | -$12.6K | 0.41% | 29 |
|
|
2023
Q2 | $2.8M | Sell |
20,755
-1,957
| -9% | -$287K | 0.34% | 36 |
|
|
2023
Q1 | $3.62M | Buy |
22,712
+501
| +2% | +$76.6K | 0.44% | 28 |
|
|
2022
Q4 | $3.59M | Buy |
22,211
+1
| +0% | +$153 | 0.44% | 24 |
|
|
2022
Q3 | $2.98M | Sell |
22,210
-2,549
| -10% | -$366K | 0.71% | 29 |
|
|
2022
Q2 | $3.79M | Sell |
24,759
-48,096
| -66% | -$7.35M | 0.47% | 26 |
|
|
2022
Q1 | $4.07M | Buy |
72,855
+39,864
| +121% | +$5.79M | 0.45% | 31 |
|
|
2021
Q4 | $4.47M | Buy |
32,991
+5,501
| +20% | +$650K | 0.57% | 33 |
|
|
2021
Q3 | $2.96M | Sell |
27,490
-5,853
| -18% | -$669K | 0.4% | 44 |
|
|
2021
Q2 | $3.76M | Sell |
33,343
-64,077
| -66% | -$7.22M | 0.45% | 43 |
|
|
2021
Q1 | $10.5M | Buy |
97,420
+63,633
| +188% | +$6.81M | 1% | 19 |
|
|
2020
Q4 | $3.62M | Buy |
33,787
+6,336
| +23% | +$609K | 0.48% | 46 |
|
|
2020
Q3 | $2.4M | Sell |
27,451
-198
| -0.7% | -$18.6K | 0.38% | 53 |
|
|
2020
Q2 | $2.71M | Buy |
27,649
+3,042
| +12% | +$268K | 0.44% | 51 |
|
|
2020
Q1 | $1.88M | Buy |
24,607
+172
| +0.7% | +$14.7K | 0.35% | 61 |
|
|
2019
Q4 | $2.16M | Hold |
24,435
| – | – | 0.33% | 71 |
|
|
2019
Q3 | $1.85M | Buy |
24,435
+2,986
| +14% | +$205K | 0.3% | 77 |
|
|
2019
Q2 | $1.56M | Sell |
21,449
-5,838
| -21% | -$459K | 0.26% | 85 |
|
|
2019
Q1 | $2.2M | Sell |
27,287
-750
| -3% | -$61.4K | 0.37% | 55 |
|
|
2018
Q4 | $2.58M | Sell |
28,037
-300
| -1% | -$26.4K | 0.49% | 41 |
|
|
2018
Q3 | $2.68M | Sell |
28,337
-2,675
| -9% | -$254K | 0.43% | 48 |
|
|
2018
Q2 | $2.87M | Sell |
31,012
-14,368
| -32% | -$1.4M | 0.48% | 42 |
|
|
2018
Q1 | $4.29M | Buy |
45,380
+3,425
| +8% | +$376K | 0.65% | 27 |
|
|
2017
Q4 | $4.06M | Sell |
41,955
-7,061
| -14% | -$665K | 0.63% | 30 |
|
|
2017
Q3 | $4.36M | Buy |
49,016
+770
| +2% | +$58.6K | 0.72% | 27 |
|
|
2017
Q2 | $3.5M | Sell |
48,246
-8,678
| -15% | -$583K | 0.57% | 36 |
|
|
2017
Q1 | $3.71M | Sell |
56,924
-6,228
| -10% | -$392K | 0.6% | 35 |
|
|
2016
Q4 | $3.96M | Sell |
63,152
-782
| -1% | -$47.7K | 0.66% | 30 |
|
|
2016
Q3 | $4.03M | Buy |
63,934
+7,700
| +14% | +$498K | 0.7% | 30 |
|
|
2016
Q2 | $3.48M | Sell |
56,234
-2,873
| -5% | -$175K | 0.59% | 36 |
|
|
2016
Q1 | $3.38M | Sell |
59,107
-1,508
| -2% | -$84.1K | 0.59% | 37 |
|
|
2015
Q4 | $3.59M | Sell |
60,615
-9,945
| -14% | -$573K | 0.61% | 33 |
|
|
2015
Q3 | $3.84M | Sell |
70,560
-9,097
| -11% | -$592K | 0.66% | 28 |
|
|
2015
Q2 | $5.35M | Buy |
79,657
+16,975
| +27% | +$1.11M | 0.82% | 20 |
|
|
2015
Q1 | $3.67M | Buy |
62,682
+23,080
| +58% | +$1.39M | 0.55% | 38 |
|
|
2014
Q4 | $2.59M | Sell |
39,602
-1,100
| -3% | -$69.3K | 0.41% | 51 |
|
|
2014
Q3 | $2.35M | Sell |
40,702
-1,200
| -3% | -$66.6K | 0.39% | 49 |
|
|
2014
Q2 | $2.37M | Hold |
41,902
| – | – | 0.37% | 49 |
|
|
2014
Q1 | $2.15M | Hold |
41,902
| – | – | 0.37% | 48 |
|
|
2013
Q4 | $2.21M | Hold |
41,902
| – | – | 0.4% | 48 |
|
|
2013
Q3 | $1.87M | Hold |
41,902
| – | – | 0.36% | 52 |
|
|
2013
Q2 | $1.73M | Buy |
+41,902
| New | +$1.83M | 0.31% | 60 |
|
Other funds holding ABBV
Wellington Shields Capital Management's ABBV Position: Q2 2026 in Review
Wellington Shields Capital Management reduced its AbbVie (ABBV) stake by 43% in Q2 2026, selling an estimated $775K and leaving 4,721 shares worth $1.19M. The position accounts for 0.15% of the portfolio, ranked #110.
Wellington Shields Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.5M in Q1 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Wellington Shields Capital Management held 4,721 shares of AbbVie worth $1.19M as of Q2 2026.
- Wellington Shields Capital Management sold 3,600 AbbVie shares in Q2 2026, an estimated $775K.
- AbbVie made up 0.15% of Wellington Shields Capital Management's portfolio in Q2 2026, its #110 holding.
- Wellington Shields Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Wellington Shields Capital Management's AbbVie position peaked at $10.5M in Q1 2021.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.